Welcome to LookChem.com Sign In|Join Free

CAS

  • or

106-28-5

Post Buying Request

106-28-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

106-28-5 Usage

Description

Farnesol is widely present in the flowers, leaves, stems and other parts of plants, especially in some Chinese herbal medicine plants and spice plants with a high content, such as Cinnamomum chinensis, Pinellia sinensis, loquat leaves, etc., which are well developed and utilized An important resource for prospects. Farnesol is one of the important active components of Chinese herbal medicine plants, and also one of the main fragrance components of some important essential oils of spice plants. Therefore, it has been widely used in medicine, pesticides, cosmetics and daily chemicals that require its biological activity.

Chemical Properties

Clear Colourless Oil

Uses

Different sources of media describe the Uses of 106-28-5 differently. You can refer to the following data:
1. Farnesol is a natural organic compound which is present in many essential oils.
2. trans,trans-Farnesol is an intermediate used in the biological synthesis of cholesterol from mevalonic acid. It is used in the perfume industry. Further, it is used in the preparation of terpenes such as squalenes, cembranoids and forskolin. It is also used in the synthesis of Cecropia juvenile hormone.

Synthesis Reference(s)

Journal of the American Chemical Society, 102, p. 3298, 1980 DOI: 10.1021/ja00529a091The Journal of Organic Chemistry, 40, p. 3617, 1975 DOI: 10.1021/jo00912a039

General Description

trans,trans-Farnesol is sesquiterpene alcohol, which is commonly found in many essential oils, citrus fruits, propolis, and plant-derived foods and beverages. It is an effective bioactive agent that can be used in pharmaceuticals and cosmetics.

Purification Methods

The main impurity is the cis-trans isomer. Purify it by gas chromatography using a 4ft x 0.125in 3%OV-1 column at 150o. [Corey et al. J Am Chem Soc 92 6637 1970, Popjak et al. J Biol Chem 237 56 1962.] It has also been fractionated through a 14-in Podbielniak column (p 11) at 11o/0.35mm. Alternatively it has been purified by gas chromatography using SF96 silicone on Fluoropak columns or Carbowax 20M on Fluoropak or base-washed 30:60 firebrick (to avoid decomposition, prepared by treating the firebrick with 5N NaOH in MeOH and washed with MeOH to pH 8) at 210o with Helium carrier gas at 60 mL/min flow rate. The diphenylcarbamoyl derivative has m 61-63o (from MeOH) and has an IR band at 3500 cm-1. [Bates et al. J Org Chem 28 1086 1963, Beilstein 1 IV 2335.]

Check Digit Verification of cas no

The CAS Registry Mumber 106-28-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,0 and 6 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 106-28:
(5*1)+(4*0)+(3*6)+(2*2)+(1*8)=35
35 % 10 = 5
So 106-28-5 is a valid CAS Registry Number.
InChI:InChI=1/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+

106-28-5 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L14348)  trans,trans-Farnesol, 97%   

  • 106-28-5

  • 1g

  • 240.0CNY

  • Detail
  • Alfa Aesar

  • (L14348)  trans,trans-Farnesol, 97%   

  • 106-28-5

  • 5g

  • 895.0CNY

  • Detail
  • Alfa Aesar

  • (L14348)  trans,trans-Farnesol, 97%   

  • 106-28-5

  • 25g

  • 2164.0CNY

  • Detail
  • Sigma-Aldrich

  • (92386)  trans,trans-Farnesol  analytical standard

  • 106-28-5

  • 92386-100MG

  • 553.41CNY

  • Detail

106-28-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name (2-trans,6-trans)-farnesol

1.2 Other means of identification

Product number -
Other names ALL TRANS FARNESOL

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:106-28-5 SDS

106-28-5Synthetic route

ethyl farnesoate
19954-66-6

ethyl farnesoate

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In diethyl ether at 0 - 20℃; Inert atmosphere;95%
With lithium aluminium tetrahydride In diethyl ether at 20℃;90%
With lithium aluminium tetrahydride In diethyl ether88%
Stage #1: ethyl farnesoate With aluminum (III) chloride; lithium aluminium tetrahydride In diethyl ether at -5℃; for 1h;
Stage #2: With sodium hydroxide
Conditions
ConditionsYield
With water; alkaline phosphatase at 37℃; for 5h; Enzymatic reaction;
With calf intestine phosphatase; magnesium chloride In hexane at 30℃; for 2h; pH=7.5; Enzymatic reaction;
With calf intestinal phosphatase; water at 37℃; for 1h; pH=7.9; Enzymatic reaction;
Conditions
ConditionsYield
With potassium hydroxide; sodium hydroxide In methanol for 24h; Reflux;85%
(E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
40716-66-3

(E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
O=W(OR)4-ligand at 180 - 200℃;
Stage #1: (E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol With vinyl acetate; Amano Lipase PS; C10H10NO6V In toluene at 50℃; for 168h; Enzymatic reaction;
Stage #2: With potassium carbonate In methanol at 0℃; for 2h; Overall yield = 67.7 %Chromat.; Optical yield = 78.947 %de; diastereoselective reaction;
(6E)-3,7,11-trimethyldodeca-2,6,10-trienal
72019-02-4

(6E)-3,7,11-trimethyldodeca-2,6,10-trienal

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; formic acid triethylamine complex; N-tosylethylenediamine In ethyl acetate at 20℃; for 20h; Inert atmosphere; Overall yield = 98 %;
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical In chlorobenzene at 130℃; for 72h; Reagent/catalyst;
(6E)-farnesyl acetate
226090-90-0

(6E)-farnesyl acetate

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With potassium carbonate In methanol at 0℃; for 2h; Overall yield = 86%; Overall yield = 1.45 mg;
With water; sodium hydroxide In methanol at 20℃; for 0.5h; Reagent/catalyst; Overall yield = 94 percent; Overall yield = 209 mg;
trans,trans-farnesyl diphenylurethane
76386-25-9

trans,trans-farnesyl diphenylurethane

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With potassium hydroxide In ethanol; water for 6h; Heating;93%
isopentenylmagnesium bromide
97344-88-2

isopentenylmagnesium bromide

3,7-dimethyl-8-<(tetrahydro-2H-pyran-2-yl)oxy>-2E,6E-octadien-1-ol
95763-58-9

3,7-dimethyl-8-<(tetrahydro-2H-pyran-2-yl)oxy>-2E,6E-octadien-1-ol

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With copper(l) iodide In tetrahydrofuran for 12h;54%
(6E)-3,7,11-trimethyldodeca-2,6,10-trienal
72019-02-4

(6E)-3,7,11-trimethyldodeca-2,6,10-trienal

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical In chlorobenzene at 130℃; for 17.5h; Reagent/catalyst;
(2E,6E)-1-(tert-butyldimethylsilyloxy)-3,7,1,1-trimethyldodeca-2,6,10-triene
61890-77-5

(2E,6E)-1-(tert-butyldimethylsilyloxy)-3,7,1,1-trimethyldodeca-2,6,10-triene

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With phosphomolybdic acid hydrate; silica gel In tetrahydrofuran at 20℃; for 0.25h;97%
trans geranyl acetone
3796-70-1

trans geranyl acetone

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: NaH / tetrahydrofuran / 2 h / 0 °C
1.2: 73 percent / tetrahydrofuran / 3 h / 0 - 20 °C
2.1: diisobutyl aluminum hydride / toluene / 1 h / -78 °C
View Scheme
Multi-step reaction with 2 steps
1: NaH; 15-crown-6 / tetrahydrofuran / -30 °C
2: LiAlH4 / benzene / 55 °C
View Scheme
Multi-step reaction with 2 steps
1: 94 percent / t-AmOK / diethyl ether
2: 2) LAH / 2) ether, 0 degC, 2.5H
View Scheme
(E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol
40716-66-3

(E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol

acetic anhydride
108-24-7

acetic anhydride

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Stage #1: (E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol; acetic anhydride With bis(acetylacetonato)dioxidomolybdenum(VI) In chloroform at 50℃; for 24h;
Stage #2: With potassium carbonate In methanol at 0℃; for 2h; Reagent/catalyst; Solvent; Temperature; Overall yield = 86 %; Overall yield = 362.5 mg;
farnesal
19317-11-4

farnesal

A

(2Z,6Z)-farnesol
16106-95-9

(2Z,6Z)-farnesol

B

2E,6Z-farnesol
3879-60-5

2E,6Z-farnesol

C

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

D

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; formic acid triethylamine complex; N-tosylethylenediamine In ethyl acetate at 20℃; for 20h; Reagent/catalyst; Temperature; Solvent; Inert atmosphere; Overall yield = 98 %;
ethyl (2Z/E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoate
33776-65-7

ethyl (2Z/E,6E)-3,7,11-trimethyldodeca-2,6,10-trienoate

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With lithium aluminium tetrahydride In benzene at 55℃;
With diisobutylaluminium hydride In toluene at -78℃; for 1h;
formic acid
64-18-6

formic acid

(+/-)-nerolidol
7212-44-4

(+/-)-nerolidol

A

(2Z,6Z)-farnesol
16106-95-9

(2Z,6Z)-farnesol

B

2E,6Z-farnesol
3879-60-5

2E,6Z-farnesol

C

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

D

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Stage #1: formic acid; (+/-)-nerolidol In hexane at 10 - 15℃; for 21h;
Stage #2: With water; sodium hydroxide In methanol at 20 - 40℃; for 2.25h;
formaldehyd
50-00-0

formaldehyd

trans geranyl acetone
3796-70-1

trans geranyl acetone

Methyltriphenylphosphonium bromide
1779-49-3

Methyltriphenylphosphonium bromide

A

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol
3790-71-4

(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Stage #1: trans geranyl acetone; Methyltriphenylphosphonium bromide With n-butyllithium In tetrahydrofuran at -78℃; for 0.75h;
Stage #2: With sec.-butyllithium In tetrahydrofuran at -78℃; for 1h;
Stage #3: formaldehyd In tetrahydrofuran at 0 - 20℃;
A 29%
B n/a
C18H27BrClF3O5S

C18H27BrClF3O5S

A

Farnesol
106-28-5

Farnesol

B

(R,2E,6E)-10-bromo-11-chloro-3,7,11-trimethyldodeca-2,6-dien-1-ol

(R,2E,6E)-10-bromo-11-chloro-3,7,11-trimethyldodeca-2,6-dien-1-ol

Conditions
ConditionsYield
With L-Selectride In tetrahydrofuran at -78 - 20℃; Inert atmosphere;A n/a
B 62%
farnesol
4602-84-0

farnesol

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 4 h / 100 - 105 °C
2: 93 percent / potassium hydroxide / ethanol; H2O / 6 h / Heating
View Scheme
formaldehyd
50-00-0

formaldehyd

(E)-6,10-dimethyl-5,9-undecadien-1-yne
22850-55-1

(E)-6,10-dimethyl-5,9-undecadien-1-yne

trimethylaluminum
75-24-1

trimethylaluminum

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With n-butyllithium; zirconocene dichloride Yield given. Multistep reaction;
(2E,6E,10E)-3,7,11-trimethyl-5-p-tolylsulphonyldodeca-2,6,10-trien-1-ol
78284-80-7

(2E,6E,10E)-3,7,11-trimethyl-5-p-tolylsulphonyldodeca-2,6,10-trien-1-ol

A

Farnesol
106-28-5

Farnesol

B

(3Z,6E)-3,7,11-trimethyldodeca-3,6,11-trien-1-ol
78284-81-8

(3Z,6E)-3,7,11-trimethyldodeca-3,6,11-trien-1-ol

C

(3Z,7E)-3,7,11-trimethyldodeca-3,7,11-trien-1-ol
78284-82-9

(3Z,7E)-3,7,11-trimethyldodeca-3,7,11-trien-1-ol

Conditions
ConditionsYield
With lithium; ethylamine In diethyl ether at -78℃; for 2.5h;A 27%
B n/a
C n/a
With lithium; ethylamine In diethyl ether at -78℃; for 2.5h; Yields of byproduct given;
Farnesal
502-67-0

Farnesal

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With manganese; water; 2,4,6-collidine hydrochloride In tetrahydrofuran at 20℃; chemoselective reaction;69%
With human aldo-keto reductase 1A1; NADPH at 25℃; pH=7.4; Kinetics; Reagent/catalyst; aq. phosphate buffer;
With sodium tetrahydroborate In methanol at 20℃; for 0.5h;
ethyl (2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate
64759-51-9

ethyl (2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenoate

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With diisobutylaluminium hydride In toluene at -70℃; for 1h; Inert atmosphere;
farnesyl pyrophosphate
104715-19-7

farnesyl pyrophosphate

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
With 2-amino-6-mercapto-7-methylpurine ribonucleoside; purine nucleoside phosphorylase; YisP from Bacillus subtilis; magnesium chloride In aq. buffer pH=7.5; Enzymatic reaction;
1-((tert-butyldiphenylsilyl)oxy)-3-methyl-2-butene
188263-82-3

1-((tert-butyldiphenylsilyl)oxy)-3-methyl-2-butene

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 37 percent / SeO2, salicylic acid, t-BuOOH, H2O / CH2Cl2 / 20 h / Ambient temperature
2: 1.) MsCl, Et3N, 2.) LiBr / 1.) CH2Cl2, -40 deg C, 1 h, 2.) THF, 0 deg C, 2 h
3: 1.) BaI2*H2O, biphenyl radical, 3.) TBAF / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 1 h, 3.) THF, 0 deg C, 1 h; room temperature, 3 h
View Scheme
3-methyl-2-buten-1-ol
556-82-1

3-methyl-2-buten-1-ol

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 82 percent / Et3N, DMAP / CH2Cl2 / 2 h / Ambient temperature
2: 37 percent / SeO2, salicylic acid, t-BuOOH, H2O / CH2Cl2 / 20 h / Ambient temperature
3: 1.) MsCl, Et3N, 2.) LiBr / 1.) CH2Cl2, -40 deg C, 1 h, 2.) THF, 0 deg C, 2 h
4: 1.) BaI2*H2O, biphenyl radical, 3.) TBAF / 1.) THF, -78 deg C, 15 min, 2.) THF, -78 deg C, 1 h, 3.) THF, 0 deg C, 1 h; room temperature, 3 h
View Scheme
Geraniol
106-24-1

Geraniol

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
3: Cu(acac)2 / tetrahydrofuran / 18 h / Ambient temperature
View Scheme
Multi-step reaction with 5 steps
1: phosphorus tribromide; pyridine / diethyl ether / -10 °C
2: potassium carbonate / acetone / 5 h / Reflux
3: potassium hydroxide / methanol / Reflux
4: sodium hydride / tetrahydrofuran; mineral oil / 20 °C
5: lithium aluminium tetrahydride / diethyl ether / 20 °C
View Scheme
trans geranyl acetone
3796-70-1

trans geranyl acetone

methoxy-ethynyl magnesium bromide

methoxy-ethynyl magnesium bromide

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 65 percent / NaH / benzene
2: 88 percent / LiAlH4 / diethyl ether
View Scheme
pseudoionone
141-10-6

pseudoionone

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: HEH, silica gel / benzene / 20 h / Heating; dark
2: 65 percent / NaH / benzene
3: 88 percent / LiAlH4 / diethyl ether
View Scheme
8-hydroxygeranyl acetate
37905-03-6

8-hydroxygeranyl acetate

Farnesol
106-28-5

Farnesol

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: PBr3 / diethyl ether / 0.33 h / -25 °C
2: BuLi, N,N'-dimethyl-N,N'-propyleneurea / hexane; tetrahydrofuran / 1.) -78 deg C, 1 h; 2.) -50 deg C, 1 h
3: KOH / diethyl ether; methanol / 1 h / Ambient temperature
4: Na, dibenzo<18>crown-6 / liquid ammonia; tetrahydrofuran / 0.03 h
View Scheme
Multi-step reaction with 3 steps
1: toluene-4-sulfonic acid / 6 h / 50 °C
2: sodium hydroxide / water; ethanol / 5 h / 20 °C
3: copper(l) iodide / tetrahydrofuran / 12 h
View Scheme
dimethylallyl diphosphate
358-72-5

dimethylallyl diphosphate

isopentenyl diphosphate
358-71-4

isopentenyl diphosphate

A

Farnesol
106-28-5

Farnesol

B

Geranylgeraniol
24034-73-9

Geranylgeraniol

Conditions
ConditionsYield
Stage #1: dimethylallyl diphosphate; isopentyl pyrophosphate With DL-dithiothreitol; ammonium chloride; magnesium chloride at 37℃; for 1h; pH=8.5; Enzymatic reaction;
Stage #2: In isopropyl alcohol at 37℃; for 12h; Enzymatic reaction;
Farnesol
106-28-5

Farnesol

Farnesal
502-67-0

Farnesal

Conditions
ConditionsYield
With oxalyl dichloride; dimethyl sulfoxide In dichloromethane at -63℃; for 0.5h;100%
With dipyridinium dichromate In dichloromethane at 0 - 25℃; for 24h;100%
With Dess-Martin periodane In dichloromethane at 20℃; Inert atmosphere;99%
Conditions
ConditionsYield
With pyridine; phosphorus tribromide In diethyl ether at 5℃; for 3h; Darkness;100%
With phosphorus tribromide In diethyl ether at 0℃; for 1h;99%
With phosphorus tribromide In pyridine99%
Conditions
ConditionsYield
Stage #1: Farnesol With 2,4,6-trimethyl-pyridine; methanesulfonyl chloride In N,N-dimethyl-formamide at 0℃; for 0.25h;
Stage #2: With lithium chloride In N,N-dimethyl-formamide at 0℃; for 3h;
100%
With N-chloro-succinimide; dimethylsulfide99.1%
With phosphorus trichloride In diethyl ether at -5 - 20℃; for 1.75h;97%
Farnesol
106-28-5

Farnesol

acetic anhydride
108-24-7

acetic anhydride

(2E,6E)-farnesyl acetate
4128-17-0

(2E,6E)-farnesyl acetate

Conditions
ConditionsYield
With dmap In pyridine for 0.5h; Ambient temperature;100%
In pyridine for 3h;99%
In pyridine for 1h; Ambient temperature;99.5%
Farnesol
106-28-5

Farnesol

1-hydroxy-3,7,11-trimethyl-6,10-dodecadiene
37519-97-4

1-hydroxy-3,7,11-trimethyl-6,10-dodecadiene

Conditions
ConditionsYield
With platinum(IV) oxide; hydrogen In ethyl acetate for 0.666667h;100%
With hydrogen; {RhCl(PPh3)2}2 In tetrahydrofuran Ambient temperature;36%
With 5% active carbon-supported ruthenium; hydrogen In methanol at 120℃; under 30402 Torr; for 16h; Autoclave; stereoselective reaction;
cycl-isopropylidene malonate
2033-24-1

cycl-isopropylidene malonate

Farnesol
106-28-5

Farnesol

3-oxo-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyloxy)propanoic acid

3-oxo-3-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyloxy)propanoic acid

Conditions
ConditionsYield
In toluene at 100℃; Inert atmosphere;100%
In toluene Heating;85%
Farnesol
106-28-5

Farnesol

trityl chloride
76-83-5

trityl chloride

((((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)methanetriyl)tribenzene

((((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)methanetriyl)tribenzene

Conditions
ConditionsYield
With dmap; triethylamine In dichloromethane at 0 - 23℃; for 32h;100%
Farnesol
106-28-5

Farnesol

3,7,11-trimethyldodecyl alcohol
6750-34-1

3,7,11-trimethyldodecyl alcohol

Conditions
ConditionsYield
With hydrogen; platinum(IV) oxide In ethyl acetate99%
With palladium 10% on activated carbon; hydrogen In ethyl acetate under 2068.65 Torr; for 5.5h;95%
With hydrogen; palladium on activated charcoal In ethanol for 21h;93%
Farnesol
106-28-5

Farnesol

2-acetoxy-ethanesulfinyl chloride
106730-50-1

2-acetoxy-ethanesulfinyl chloride

Acetic acid 2-((2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyloxysulfinyl)-ethyl ester
125417-10-9

Acetic acid 2-((2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyloxysulfinyl)-ethyl ester

Conditions
ConditionsYield
With pyridine at -20℃; for 0.583333h;99%
With pyridine97%
Farnesol
106-28-5

Farnesol

tert-butyldimethylsilyl chloride
18162-48-6

tert-butyldimethylsilyl chloride

(2E,6E)-1-(tert-butyldimethylsilyloxy)-3,7,1,1-trimethyldodeca-2,6,10-triene
61890-77-5

(2E,6E)-1-(tert-butyldimethylsilyloxy)-3,7,1,1-trimethyldodeca-2,6,10-triene

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 20℃;99%
With 1H-imidazole In tetrahydrofuran at 0 - 20℃; for 12h; Inert atmosphere;99%
With dmap; triethylamine In dichloromethane for 6h; Ambient temperature;95%
With 1H-imidazole In N,N-dimethyl-formamide at 20℃;
Farnesol
106-28-5

Farnesol

ethyl isocyanate
109-90-0

ethyl isocyanate

ethyl 2E,6E-farnesyl carbamate

ethyl 2E,6E-farnesyl carbamate

Conditions
ConditionsYield
With pyridine; dmap for 3h; Ambient temperature;99%
Farnesol
106-28-5

Farnesol

tert-butylchlorodiphenylsilane
58479-61-1

tert-butylchlorodiphenylsilane

(2E,6E)-1-((tert-butyldiphenylsilyl)oxy)-3,7,11-trimethyl-2,6,10-dodecatriene
151409-23-3

(2E,6E)-1-((tert-butyldiphenylsilyl)oxy)-3,7,11-trimethyl-2,6,10-dodecatriene

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 0 - 20℃; Inert atmosphere;99%
With 1H-imidazole In dichloromethane; N,N-dimethyl-formamide99%
With 1H-imidazole In dichloromethane at 0℃; for 1h;
Farnesol
106-28-5

Farnesol

ethyl vinyl ether
109-92-2

ethyl vinyl ether

(2E,6E)-1-(1-ethoxyethoxy)-3,7,11-trimethyldodeca-2,6,10-triene
1298063-48-5

(2E,6E)-1-(1-ethoxyethoxy)-3,7,11-trimethyldodeca-2,6,10-triene

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In dichloromethane at 0℃; for 2h; Inert atmosphere;99%
Farnesol
106-28-5

Farnesol

(-)-α-cuprenene

(-)-α-cuprenene

Conditions
ConditionsYield
With sesquiterpene synthases Cop6 from Coprinus cinereus In terpene synthase buffer at 25℃; for 18h; Enzymatic reaction;98.2%
Farnesol
106-28-5

Farnesol

A

N,N,2-trimethylpropionamide
21678-37-5

N,N,2-trimethylpropionamide

B

2(E),6(E)-farnesyl iodide
89111-65-9

2(E),6(E)-farnesyl iodide

Conditions
ConditionsYield
With 1-iodo-N,N,2-trimethylprop-1-en-1-amine In dichloromethane 1.) 0 deg C; 2.) rt., 3h;A n/a
B 98%
3,4-dihydro-2H-pyran
110-87-2

3,4-dihydro-2H-pyran

Farnesol
106-28-5

Farnesol

2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)tetrahydro-2H-pyran
79577-53-0, 110990-63-1, 120732-61-8, 120732-65-2, 67858-93-9

2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)tetrahydro-2H-pyran

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In dichloromethane at 25℃; Addition;98%
With pyridinium p-toluenesulfonate In dichloromethane at 25℃; for 1h;98%
With toluene-4-sulfonic acid98%
Farnesol
106-28-5

Farnesol

acetyl chloride
75-36-5

acetyl chloride

(2E,6E)-farnesyl acetate
4128-17-0

(2E,6E)-farnesyl acetate

Conditions
ConditionsYield
With pyridine In dichloromethane at 20℃; for 23h; Inert atmosphere;98%
With dmap; triethylamine at 0℃; for 3h;93%
Farnesol
106-28-5

Farnesol

((2S,3S)-3-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl)methanol
147127-72-8

((2S,3S)-3-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl)methanol

Conditions
ConditionsYield
With titanium(IV) isopropylate; tert.-butylhydroperoxide; L-(+)-diisopropyl tartrate; 4 A molecular sieve In dichloromethane at -34℃;97%
With titanium(IV) isopropylate; tert.-butylhydroperoxide; diethyl (2R,3R)-tartrate In decane; dichloromethane; acetonitrile at -40℃; for 10h; Sharpless Asymmetric Epoxidation; Inert atmosphere; Molecular sieve; Cooling with ice;95%
With diethyl (2R,3R)-tartrate87%
Farnesol
106-28-5

Farnesol

2-nitro-benzaldehyde
552-89-6

2-nitro-benzaldehyde

Farnesal
502-67-0

Farnesal

Conditions
ConditionsYield
With hydrogenchloride; aluminum isopropoxide In n-heptane; cyclohexane; water; acetone97%
With hydrogenchloride; aluminum isopropoxide In hexane; benzene93%
TETRAHYDROPYRANE
142-68-7

TETRAHYDROPYRANE

Farnesol
106-28-5

Farnesol

2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)tetrahydro-2H-pyran
79577-53-0, 110990-63-1, 120732-61-8, 120732-65-2, 67858-93-9

2-(((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy)tetrahydro-2H-pyran

Conditions
ConditionsYield
With pyridinium p-toluenesulfonate In dichloromethane at 20℃; for 3h;97%
Conditions
ConditionsYield
With diacetato[(R)-(+)-2,2-bis(di-p-tolylphosphono)-1,1′−binaphthyl]ruthenium(II); hydrogen In methanol at 20℃; under 26252.6 Torr; for 5h; High pressure; Autoclave; enantioselective reaction;96%
With hydrogen; [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; ((R)-(+)-2,2'-bis(diphenylphosphino)-1,1'-binaphthyl)chloro( In methanol under 72402.6 Torr; for 24h; Hydrogenation;95%
With Ru2Cl4-((R)-2,2'-bis[di(p-tolyl)phosphino]-1,1'-binaphthyl)2N(ethyl)3; hydrogen In methanol at 20℃; under 30402 Torr; for 16h; Autoclave; stereoselective reaction;82%
2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-1-octanol
307-30-2

2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-1-octanol

Farnesol
106-28-5

Farnesol

(2E,6E)-3,7,11-Trimethyl-1-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-octyloxy)-dodeca-2,6,10-triene

(2E,6E)-3,7,11-Trimethyl-1-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-pentadecafluoro-octyloxy)-dodeca-2,6,10-triene

Conditions
ConditionsYield
With tributylphosphine; 1,1'-azodicarbonyl-dipiperidine In benzene for 2h; Ambient temperature;95%
(E)-3-phenylpropenal
14371-10-9

(E)-3-phenylpropenal

Farnesol
106-28-5

Farnesol

(E)-cinnamic acid (2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyl ester
128638-94-8

(E)-cinnamic acid (2E,6E)-3,7,11-trimethyl-dodeca-2,6,10-trienyl ester

Conditions
ConditionsYield
Stage #1: Farnesol With 1,8-diazabicyclo[5.4.0]undec-7-ene; 1,4-dimethyl-1,2,4-triazolium iodide In tetrahydrofuran for 0.0833333h; Inert atmosphere;
Stage #2: (E)-3-phenylpropenal With 3,5,3',5'-tetra-tert-butyl-4,4'-diphenoquinone In tetrahydrofuran at 20℃; for 2h; Inert atmosphere;
95%
Farnesol
106-28-5

Farnesol

triisopropylsilyl chloride
13154-24-0

triisopropylsilyl chloride

(2E,6E)-farnesyl triisopropylsilyl ether
1026784-62-2

(2E,6E)-farnesyl triisopropylsilyl ether

Conditions
ConditionsYield
With 1H-imidazole In N,N-dimethyl-formamide at 20℃; for 60h;94%
Conditions
ConditionsYield
With germacrene A synthase from Nostoc sp. PCC7120 (NS1) In terpene synthase buffer at 25℃; for 18h; Enzymatic reaction;93.5%
Farnesol
106-28-5

Farnesol

(2R,3R)-3-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl-methanol
85505-95-9

(2R,3R)-3-((E)-4,8-dimethylnona-3,7-dien-1-yl)-3-methyloxiran-2-yl-methanol

Conditions
ConditionsYield
With titanium(IV) isopropylate; D-(-)-diisopropyl tartrate In dichloromethane; tert-butyl alcohol at -45℃; Molecular sieve; Inert atmosphere;93%
With titanium(IV) isopropylate; tert.-butylhydroperoxide; diethyl (2R,3R)-tartrate in the presence of molecular sieves;92%
With titanium(IV) isopropylate; tert.-butylhydroperoxide; (-)-diethyl tartrate In dichloromethane at -50 - -45℃; for 1h;84%
phthalimide
136918-14-4

phthalimide

Farnesol
106-28-5

Farnesol

N-farnesylphtalimide
123022-37-7

N-farnesylphtalimide

Conditions
ConditionsYield
With Zn(N3)2/bis-pyridine complex; di-isopropyl azodicarboxylate; triphenylphosphine In tetrahydrofuran for 4h; Ambient temperature;93%
Mitsunobu reaction;

106-28-5Relevant articles and documents

Structural and functional analysis of bacillus subtilis yisp reveals a role of its product in biofilm production

Feng, Xinxin,Hu, Yumei,Zheng, Yingying,Zhu, Wei,Li, Kai,Huang, Chun-Hsiang,Ko, Tzu-Ping,Ren, Feifei,Chan, Hsiu-Chien,Nega, Mulugeta,Bogue, Shannon,Lpez, Daniel,Kolter, Roberto,G?tz, Friedrich,Guo, Rey-Ting,Oldfield, Eric

, p. 1557 - 1563 (2014)

YisP is involved in biofilm formation in Bacillus subtilis and has been predicted to produce C30 isoprenoids. We determined the structure of YisP and observed that it adopts the same fold as squalene and dehydrosqualene synthases. However, the first aspartate-rich motif found in essentially all isoprenoid synthases is aspartate poor in YisP and cannot catalyze head-to-head condensation reactions. We find that YisP acts as a phosphatase, catalyzing formation of farnesol from farnesyl diphosphate, and that it is the first phosphatase to adopt the fold seen in the head-to-head prenyl synthases. Farnesol restores biofilm formation in a Δyisp mutant and modifies lipid membrane structure similarly to the virulence factor staphyloxanthin. This work clarifies the role of YisP in biofilm formation and suggests an intriguing possibility that many of the YisP-like homologs found in other bacteria may also have interesting products and functions.

Molecular cloning and characterization of drimenol synthase from valerian plant (Valeriana officinalis)

Kwon, Moonhyuk,Cochrane, Stephen A.,Vederas, John C.,Ro, Dae-Kyun

, p. 4597 - 4603 (2014)

Drimenol, a sesquiterpene alcohol, and its derivatives display diverse bio-activities in nature. However, a drimenol synthase gene has yet to be identified. We identified a new sesquiterpene synthase cDNA (VoTPS3) in valerian plant (Valeriana officinalis). Purification and NMR analyses of the VoTPS3-produced terpene, and characterization of the VoTPS3 enzyme confirmed that VoTPS3 synthesizes (-)-drimenol. In feeding assays, possible reaction intermediates, farnesol and drimenyl diphosphate, could not be converted to drimenol, suggesting that the intermediate remains tightly bound to VoTPS3 during catalysis. A mechanistic consideration of (-)-drimenol synthesis suggests that drimenol synthase is likely to use a protonation-initiated cyclization, which is rare for sesquiterpene synthases. VoTPS3 can be used to produce (-)-drimenol, from which useful drimane-type terpenes can be synthesized.

Roles of rat and human aldo-keto reductases in metabolism of farnesol and geranylgeraniol

Endo, Satoshi,Matsunaga, Toshiyuki,Ohta, Chisato,Soda, Midori,Kanamori, Ayano,Kitade, Yukio,Ohno, Satoshi,Tajima, Kazuo,El-Kabbani, Ossama,Hara, Akira

, p. 261 - 268 (2011)

Farnesol (FOH) and geranylgeraniol (GGOH) with multiple biological actions are produced from the mevalonate pathway, and catabolized into farnesoic acid and geranylgeranoic acid, respectively, via the aldehyde intermediates (farnesal and geranylgeranial). We investigated the intracellular distribution, sequences and properties of the oxidoreductases responsible for the metabolic steps in rat tissues. The oxidation of FOH and GGOH into their aldehyde intermediates were mainly mediated by alcohol dehydrogenases 1 (in the liver and colon) and 7 (in the stomach and lung), and the subsequent step into the carboxylic acids was catalyzed by a microsomal aldehyde dehydrogenase. In addition, high reductase activity catalyzing the aldehyde intermediates into FOH (or GGOH) was detected in the cytosols of the extra-hepatic tissues, where the major reductase was identified as aldo-keto reductase (AKR) 1C15. Human reductases with similar specificity were identified as AKR1B10 and AKR1C3, which most efficiently reduced farnesal and geranylgeranial among seven enzymes in the AKR1A-1C subfamilies. The overall metabolism from FOH to farnesoic acid in cultured cells was significantly decreased by overexpression of AKR1C15, and increased by addition of AKR1C3 inhibitors, tolfenamic acid and R-flurbiprofen. Thus, AKRs (1C15 in rats, and 1B10 and 1C3 in humans) may play an important role in controlling the bioavailability of FOH and GGOH.

Corey,E.J. et al.

, p. 4245 - 4247 (1967)

Substrate specificities of E- and Z-farnesyl diphosphate synthases with substrate analogs

Nagaki, Masahiko,Ichijo, Takumi,Kobashi, Rikiya,Yagihashi, Yusuke,Musashi, Tohru,Kawakami, Jun,Ohya, Norimasa,Gotoh, Takeshi,Sagami, Hiroshi

, p. 1 - 6 (2012)

Prenyltransferases catalyzes the basic isoprenoid chain elongation to produce prenyl diphosphates, which led to upward of 30,000 diverse isoprenoids as steroids, carotenoids, natural rubbers, and prenyl proteins. Here, we determined the reactivities of E- and Z-farnesyl diphosphate synthases (E- and Z-FPP synthases) isolated from Bacillus stearothermophilus and Thermobifida fusca, respectively. For this purpose we use the synthetic substrate analogs, 8-tetrahydropyran-2-yloxy-, 8-hydroxy- and 8-acetoxygeranyl diphosphates. Z-FPP synthase catalyzed the reaction between 8-hydroxygeranyl diphosphate (HOGPP) and isopentenyl diphosphate (IPP), which produced (2Z)-12-hydroxyfarnesyl diphosphate (yield: 16.7%) and (2Z, 6Z)-16-hydroxygeranylgeranyl diphosphate (yield: 6.6%). Neither E- nor Z-farnesyl diphosphate synthases detectably catalyzed reactions between 8-tetrahydropyran-2-yloxygeranyl diphosphate (8-THPOGPP) and IPP. However, a mutated E-FPP synthase (Y81S), did catalyze this reaction, producing 12-tetrahydropyran-2-yloxyfarnesyl diphosphate (12-THPOFPP) with a yield of 12.3%. Wild-type E-FPP synthase catalyzed the reaction of 8-acetoxygeranyl diphosphate (8-AcOGPP) with IPP, which produced 12-acetoxyfarnesyl diphosphate (12-AcOFPP) (yield, 21.8%). Mutant E-FPP synthase catalyzed the reaction between 8-AcOGPP with IPP, producing 12-AcOFPP and 16-acetoxygeranylgeranyl diphosphate (16-AcOGGPP) with respective yields of 55.3% and 1.7%. We believe our results contribute to a better understanding of the catalytic properties of these key enzymes and illustrate their use in the stereo-specific syntheses of compounds that may have significant biotechnological and medical applications.

-

Corey,E.J.,Kirst,H.A.

, p. 5041 - 5043 (1968)

-

Regiospecific Synthesis of Calcium-Independent Daptomycin Antibiotics using a Chemoenzymatic Method

Mupparapu, Nagaraju,Lin, Yu-Hsin Cindy,Kim, Tae Ho,Elshahawi, Sherif I.

supporting information, p. 4176 - 4182 (2021/02/01)

Daptomycin (DAP) is a calcium (Ca2+)-dependent FDA-approved antibiotic drug for the treatment of Gram-positive infections. It possesses a complex pharmacophore hampering derivatization and/or synthesis of analogues. To mimic the Ca2+-binding effect, we used a chemoenzymatic approach to modify the tryptophan (Trp) residue of DAP and synthesize kinetically characterized and structurally elucidated regiospecific Trp-modified DAP analogues. We demonstrated that the modified DAPs are several times more active than the parent molecule against antibiotic-susceptible and antibiotic-resistant Gram-positive bacteria. Strikingly, and in contrast to the parent molecule, the DAP derivatives do not rely on calcium or any additional elements for activity.

METHOD FOR PRODUCING CARBOXYLIC ACID PRENYL AND PRENOL

-

Paragraph 0086-0099, (2019/12/31)

PROBLEM TO BE SOLVED: To provide a method for producing carboxylic acid prenyls and prenols in high yields and in an industrial and economical advantageous manner. SOLUTION: A production method includes reacting a prenyl amine represented by formula (1), in the presence of a halide, with a carboxylic acid anhydride represented by formula (2), to produce a carboxylic acid prenyl represented by formula (3), and further subjecting the carboxylic acid prenyl to solvolysis, to obtain a prenol represented by formula (6). SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

Enantiospecific Solvolytic Functionalization of Bromochlorides

Burckle, Alexander J.,Gál, Bálint,Seidl, Frederick J.,Vasilev, Vasil H.,Burns, Noah Z.

supporting information, p. 13562 - 13569 (2017/10/05)

Herein, we report that under mild solvolytic conditions, enantioenriched bromochlorides can be ionized, stereospecifically cyclized to an array of complex bromocyclic scaffolds, or intermolecularly trapped by exogenous nucleophiles. Mechanistic investigations support an ionic mechanism wherein the bromochloride serves as an enantioenriched bromonium surrogate. Several natural product-relevant motifs are accessed in enantioenriched form for the first time with high levels of stereocontrol, and this technology is applied to the scalable synthesis of a polycyclic brominated natural product. Arrays of nucleophiles including olefins, alkynes, heterocycles, and epoxides are competent traps in the bromonium-induced cyclizations, leading to the formation of enantioenriched mono-, bi-, and tricyclic products. This strategy is further amenable to intermolecular coupling between cinnamyl bromochlorides and a diverse set of commercially available nucleophiles. Collectively, this work demonstrates that enantioenriched bromonium chlorides are configurationally stable under solvolytic conditions in the presence of a variety of functional groups.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 106-28-5